As of April 30, 2025, Global Health Limited (Medanta) (MEDANTA.NS) has a market cap of $3.72 billion USD. According to our data, Global Health Limited (Medanta) is ranked No.3091 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 30, 2025 | $3.72 B |
9.25%
|
Dec 31, 2024 | $3.40 B |
12.44%
|
Dec 29, 2023 | $3.03 B |
104.60%
|
Dec 30, 2022 | $1.48 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Johnson & Johnson
JNJ
|
$375.13 B |
0.006 M
|
![]() USA
|
![]() Pfizer
PFE
|
$130.73 B |
-0.001 M
|
![]() USA
|
![]() Merck
MRK
|
$212.01 B |
-0.001 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$77.05 B |
0.003 M
|
![]() UK
|
![]() Novartis
NVS
|
$224.23 B |
0.160 B
|
![]() Switzerland
|
![]() Sanofi
SNY
|
$128.86 B |
0.003 M
|
![]() France
|
![]() AstraZeneca
AZN
|
$222.30 B |
0.004 M
|
![]() UK
|
![]() AbbVie
ABBV
|
$342.32 B |
-0.001 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$794.90 B |
-0.026 M
|
![]() USA
|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$18.23 B |
0.362 B
|
![]() Israel
|
Market Cap | = | MEDANTA.NS Stock Price | * | MEDANTA.NS Shares Outstanding |
= | $13.84 | * | 0.27 B | |
= | $3.72 B |